A new clinical trial reveals that low-dose lithium aspartate is ineffective for long COVID brain fog and fatigue, yet exploratory results suggest that higher doses could hold future potential for relief. Study: Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction. Image Credit: Yellow_man / Shutterstock A recent study published in JAMA Network Open investigated the effects … Read more
A landmark study uncovers how a specific lung gene, FOXP4, raises the risk of persistent symptoms after COVID-19, providing fresh insight into why some people are more susceptible to long COVID than others. The 24 studies contributing to the Long COVID HGI data freeze 4 served as the discovery cohorts for the GWAS meta-analyses. Each … Read more
Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI designed, mutation resistant broad neutralizing antibodies against multiple SARS-CoV-2 strains. Image Credit: Lightspring / Shutterstock In a recent study in the journal Scientific Reports, researchers tested and leveraged several cutting-edge technologies, including machine … Read more
Despite heightened obstetric risks, pregnant women may face a lower chance of developing Long COVID—findings that challenge assumptions and call for deeper insight into the immune landscape of pregnancy. Study: Long COVID after SARS-CoV-2 during pregnancy in the United States. Image Credit: Natalia Deriabina / Shutterstock In a recent study published in the journal Nature Communications, researchers … Read more
Brazilian researchers reveal that even mild cases of COVID-19 can temporarily reduce heart rate variability, with stress on the autonomic nervous system lasting up to six months—especially in older individuals. Study: Impact of COVID-19 on heart rate variability in post-COVID individuals compared to a control group. Image Credit: Swetochka / Shutterstock.com Several studies have reported that … Read more
A new rapid review finds that full vaccination may reduce the odds of post-COVID-19 condition (PCC) by 27%, though more research is needed—especially in children and immunocompromised groups. Study: Does COVID-19 vaccination reduce the risk and duration of post COVID-19 condition? Image Credit: KomootP/Shutterstock.com A recent rapid review published by the European Center for Disease Prevention and … Read more
Struggling with long COVID symptoms? New research confirms that pulmonary rehabilitation can restore lung function, reduce fatigue, and improve quality of life—especially with targeted exercises over 4-8 weeks. Find out how rehabilitation could be the key to regaining your health! Study: Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis … Read more
New research reveals that even mild COVID-19 can silently worsen heart health, accelerating plaque buildup and inflammation—raising the risk of future heart attacks and strokes. Study: SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events. Image Credit: Rocos / Shutterstock In a recent study published in the journal Radiology, a research … Read more
Pediatric long COVID marked by heightened inflammation, mirroring adult cases. Proteomic profiling achieved 93% accuracy in identifying affected children, paving the way for future diagnostic advancements. Study: Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls. Image Credit: Vitalii Stock/Shutterstock.com A recent study published in Pediatric Research investigated the unique inflammatory and angiogenetic protein markers in … Read more
Evidence shows weak antiviral activity and no improvement in symptom outcomes. Study: Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). Image Credit: luchschenF/Shutterstock.com In a recent study published in eClinicalMedicine, researchers characterized the antiviral activity of a selective serotonin reuptake inhibitor (SSRI), fluoxetine, in early coronavirus disease 2019 (COVID-19). … Read more